Live
FierceBiotechEnterprise reports phase 2 cystic fibrosis win, succeeding where Big Pharma stumbledLabiotechThe real reason CGT programs struggle to scaleFierceBiotechBristol Myers Squibb inks $15B biobucks deal to bag Hengrui assets, tap China’s R&D speedeLifeEndogenous corazonin signaling modulates the post-mating switch in behavior and physiology in females of the brown planthopper and <i>Drosophila</i>IlluminaHow Illumina employees work to move healthcare toward precision medicine - IlluminaAgilentAgilent's top executives join Jefferies healthcare fireside chat June 3 - Stock TitanAgilentAgilent to Participate in Jefferies Global Healthcare Conference - Business WireEndpoints NewsOptum Rx unveils pharmacy model with clear fees, building on transparency pushThermo FisherThermo Fisher Expands Cell Therapy And Hydration Platforms To Deepen Ecosystem - Yahoo FinanceClinical OMICsFactors Predicting Poor Outcomes in Hypertrophic Cardiomyopathy UncoveredClinical OMICsSlow-Growing Breast Cancer Cells May Explain Why Relapse Happens Decades LaterClinical OMICsAsthma Drug Formoterol Shows Potential to Reverse MASH
BioWorld Mar 27, 2026

Regulatory actions for March 27, 2026

Regulatory actions for March 27, 2026

Original
Body unavailable. Use the original source.